Pancreatic Cancer Research

ResearcherActive in the last 2 years

Dandan Gu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-4082-427X; OpenAlex author ID A5067513696. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 2 papers · 2026: 2 papers

Papers 4

  1. Efferocytosis-related biomarkers and immune infiltration in pancreatic ductal adenocarcinoma based on single-cell sequencing and machine learning: a comprehens… First author DOI 10.1016/j.bbrc.2026.153751↗
  2. Integrating network pharmacology, molecular docking, and experimental validation to investigate the therapeutic effects and potential mechanisms of lycopene ag… First author DOI 10.3389/fnut.2026.1815515↗
  3. Exploring the functional and prognostic roles of EPHX4 in pancreatic cancer: Insights from bioinformatics and experimental validation. First author DOI 10.1016/j.gene.2025.149504↗
  4. Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024. Co-author DOI 10.3389/fphar.2025.1564561↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shaoyang Huang · 3 shared papers, 2025–2026 · strength 1.23
  2. Wei Xiong · 1 shared paper, 2026 · strength 0.50
  3. Wei Xiong · 1 shared paper, 2025 · strength 0.42
  4. Shaoyang Huang · 1 shared paper, 2026 · strength 0.33
  5. Wei Xiong · 1 shared paper, 2026 · strength 0.33
  6. Kai Zhao · 1 shared paper, 2025 · strength 0.30
  7. Wei Xiong · 1 shared paper, 2025 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.